TriPollar STOP VX2 vs NEWA

Disclosure: Glow & Current earns a commission when you buy through links on this page, at no extra cost to you. It does not change which device wins or what we say about it — here is exactly how we are funded, and here is how we evaluate devices.

TriPollar's evidence is specification. It tells you the temperature it targets and how it holds it. You can reason about whether that temperature is in the band collagen responds to, and the sensor means the device is checking rather than hoping.

NEWA's evidence is regulatory. A De Novo authorization means the FDA assessed the device's safety and effectiveness directly, because no predicate existed to compare it to. That is a substantively different and higher bar from a 510(k).

Neither is obviously better. They answer different questions, and which you weight more heavily is a genuine judgment call rather than something we can settle for you.

Quick picks

The short answer

#	Product	Best for	FDA clearance	Price
1	TriPollar STOP VX2 Wins on published specification	anyone who wants a number to reason about	Located	Check price on Amazon #ad How we are funded
2	NEWA Skin Care Device Wins on regulatory strength	anyone who weights an FDA evaluation above a spec sheet	Located	Check price on Amazon #ad How we are funded

Prices are checked live and stamped with the date they were read. No live price is held for these listings right now, so every button reads “Check price on Amazon” rather than showing a number we cannot stand behind. Last price check: October 13, 2026.

When EndyMed sought authorization, there was no legally marketed predicate device to claim equivalence to. The De Novo pathway required the FDA to evaluate the device on its own evidence and decide whether to create a classification for it.

That is a real distinction from the 510(k) route, where the argument is comparative. It is also from 2015, which cuts both ways: a longer track record, and an older device.

41.6 degrees Celsius is a figure you can take to the literature and argue about. It is also a figure Pollogen can be held to.

More importantly, the thermal-mapping sensor means the device is measuring rather than assuming. On a handheld device that you move across areas of different thickness and vascularity, the difference between targeting a temperature and measuring it is not small.

Pollogen also builds professional clinic RF systems, which is a reasonable signal about engineering depth even though it tells you nothing directly about the home device.

• NEWA publishes a defined protocol, an intensive phase then maintenance, which is genuinely useful and more than many brands supply.
• TriPollar publishes per-area times, which is the figure you need to plan your week.
• TriPollar adds muscle activation. NEWA does not, so a TriPollar is closer to a two-mechanism device.
• Both need a dedicated RF gel. Neither works with microcurrent gel.
• NEWA's industrial design is older. That is cosmetic rather than functional, but it is noticeable.

In detail

Every pick, and why

Illustrative photograph. Not a picture of this model.

Check price on Amazon

#ad How we are funded

Wins on published specification

TriPollar STOP VX2

TriPollar (Pollogen) · Best for anyone who wants a number to reason about

Up to 41.6 C with real-time thermal mapping and Dynamic Muscle Activation, from a manufacturer that also builds professional clinic systems. Clearance family K220322 and K203665.

Multi-frequency radiofrequency with muscle activation and a thermal sensor, from the clinical-device manufacturer Pollogen.

Specifications

Technology	Multi-RF across three frequencies, plus Dynamic Muscle Activation
Target temperature	Up to 41.6 C with thermal-mapping control
Session	4 minutes per area; full face 15-20 minutes
Clearance	K220322 / K203665, product code PAY

FDA clearance located

Pollogen's STOP U (model UXV) line holds 510(k) K220322 (4 May 2023) and K203665 (25 February 2021), product code PAY - RF device for non-invasive skin treatment.

What works

• Located clearances from a manufacturer that also builds professional clinic systems
• Publishes its target skin temperature, which is the number that actually governs RF outcomes
• Muscle activation is a real second mechanism, not a mode name

What does not

• 15-20 minutes for a full face is the longest routine on this site
• Needs a dedicated RF gel every session
• The clearance records are for the STOP U line, not the VX2 name specifically

Specifications from Pollogen product page; FDA 510(k) K220322, checked 13 October 2026.

Illustrative photograph. Not a picture of this model.

Check price on Amazon

#ad How we are funded

Wins on regulatory strength

NEWA Skin Care Device

NEWA (EndyMed) · Best for anyone who weights an FDA evaluation above a spec sheet

De Novo DEN150005, December 2015, EndyMed Medical. The FDA evaluated safety and effectiveness directly rather than matching a predicate, and created a classification. Nothing else on this site has one. Older design, no published temperature.

The home RF device with the strongest regulatory paper trail here: a De Novo authorization rather than a substantial-equivalence clearance.

Specifications

Technology	Multi-source radiofrequency
Protocol	Intensive phase then maintenance; manufacturer publishes a defined schedule
Regulatory route	De Novo DEN150005, which created the classification rather than matching one

FDA clearance located

De Novo DEN150005 (NEWA Skin Therapy System, 18 December 2015, EndyMed Medical Ltd.), with an earlier 510(k) K130793 (16 August 2013). Product codes PAY and GEI.

What works

• A De Novo authorization is a stronger regulatory signal than a 510(k) and almost nobody here has one
• Published, defined treatment schedule
• Long track record

What does not

• Older industrial design than the TriPollar line
• Requires its own gel
• No muscle-activation mechanism

Specifications from FDA De Novo DEN150005; 510(k) K130793, checked 13 October 2026.